Tominersen | Interleukin Related interleukin-related.com

Product Name :
Tominersen

Search keywords :
Tominersen

drugId :
null

Target Vo:
Huntingtin

Target Vo Short Name :
Huntingtin

Moa_Name:
Huntingtin inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Ionis Pharmaceuticals Inc

Active Company_Name :
F. Hoffmann-La Roche Ag

Active Indication_Name:
Huntington Disease

In Active Indication_Name:

Termination Status :

China Termination Status :
Phase 3 Clinical

Highest Status:
Phase 3 Clinical

China Highest Status:
Discontinued

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Tusamitamab ravtansine Purity
Botensilimab MedChemExpress
Ku80 Antibody: Ku80 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 83 kDa, targeting to Ku80. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts